Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density

Anti-malarial pre-erythrocytic vaccines (PEV) target transmission by inhibiting human infection but are currently partially protective. It has been posited, but never demonstrated, that co-administering transmission-blocking vaccines (TBV) would enhance malaria control. We hypothesized a mechanism t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherrard-Smith, Ellie, Sala, Katarzyna A, Betancourt, Michael, Upton, Leanna M, Angrisano, Fiona, Morin, Merribeth J, Ghani, Azra C, Churcher, Thomas S, Blagborough, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Epidemiology and Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008048/
https://www.ncbi.nlm.nih.gov/pubmed/29914622
http://dx.doi.org/10.7554/eLife.35213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008048/
https://www.ncbi.nlm.nih.gov/pubmed/29914622
http://dx.doi.org/10.7554/eLife.35213

Ejemplares similares